[Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma]

原文： 2023 年发布于 Gan To Kagaku Ryoho 50 卷第 1 期 97-101  浏览量：247次

作者： Hatakeyama S. Ohyama C.

作者单位： Department of Surgery, Peter MacCallum Cancer Centre, East Melbourne, Australia - siska.vanbruwaene@gmail.com.

归属分类：膀胱肿瘤临床实践指南

DOI： 10.1016/j.cca.2018.01.039

文献简介

暂无

Update on Flat and Papillary Urothelial Lesions: Genitourinary Pathology Society Consensus Recommendations

Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

热门文献

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

 Clin Invest Med 1298
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

 J Cancer Res Ther 39 卷第 6 期 905
吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

 PeerJ 60 卷第 5 期 868
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

 Int J Nurs Pract 13 卷第 4 期 807
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

 Bmc Urology 754
Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

 Oncotarget 731
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

 Eur J Nutr 11 卷第 2 期 721
[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

 Front Endocrinol (Lausanne) 13 卷第 11 期 712
膀胱癌标本规范化处理和病理诊断共识

 中华病理学杂志 49卷第4期 692
Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

 International Journal of Urology 684

[Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma]

原文： 2023 年发布于 Gan To Kagaku Ryoho 50 卷第 1 期 97-101  浏览量：247次

文献简介

上一篇

Update on Flat and Papillary Urothelial Lesions: Genitourinary Pathology Society Consensus Recommendations

下一篇

Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

膀胱癌标本规范化处理和病理诊断共识

Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

[Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma]

原文： 2023 年 发布于 Gan To Kagaku Ryoho 50 卷 第 1 期 97-101  浏览量：247次

文献简介

上一篇

下一篇

原文： 2023 年发布于 Gan To Kagaku Ryoho 50 卷第 1 期 97-101  浏览量：247次